Hipra Nordic ApS
Private limited companyCVR 35407464VejenActive
Hipra Nordic ApS is a private limited company, based in Vejen, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2013. Net profit rose 19% from 2024 to 2025, ending at DKK 4.5m. Profit has grown three years in a row. Equity grew to DKK 26.2m in 2025.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 11% (2024 → 2025), to DKK 18.3m.
- Net profit rose 19% (2024 → 2025), to DKK 4.5m.
- Equity rose 21% (2024 → 2025), to DKK 26.2m.
Management and owners, last 24 months
- New in management: David Caballero Tomás (director, 21/02/2025) and Peter Cyriel A.Saey (director, 21/02/2025).
- Stepped down: David Nogareda Estivill (director, 20/02/2025), Carlos Montañes Estupiña (director, 20/02/2025) and Peter Cyriel A.Saey (director, 30/09/2026).
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 10,934 | 13,920 | 13,987 | 14,661 | 16,462 | 18,263 | +10.9% |
| Operating profit (EBIT) | – | 3,550 | 3,518 | 3,363 | 4,781 | – | – |
| Profit before tax | 2,075 | 3,509 | 3,318 | 3,446 | 4,975 | 5,898 | +18.6% |
| Net profit | 1,580 | 2,680 | 2,568 | 2,640 | 3,801 | 4,531 | +19.2% |
| Total assets | 16,893 | 18,603 | 19,051 | 20,968 | 25,514 | 31,475 | +23.4% |
| Equity | 9,952 | 12,632 | 15,199 | 17,840 | 21,641 | 26,172 | +20.9% |
| Liabilities | 6,941 | 5,972 | 3,852 | 3,128 | 3,873 | 5,303 | +36.9% |
| Cash and cash equivalents | 118 | 304 | 152 | 133 | 1,366 | 706 | −48.3% |
| Average number of employees | 10 | 11 | 11 | 12 | 12 | 12 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 25/03/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 07/03/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 10/04/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 24/03/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 07/03/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 25/02/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 1,752of 69,742 Better than 97% | No. 4,867of 69,964 Better than 93% |
| Same industry and fewer than 20 employees150 companies in the comparison | No. 23of 150 Better than 85% | No. 26of 150 Better than 83% |
| Companies that are between 5 and 14 years old33,688 companies in the comparison | No. 2,262of 33,588 Better than 93% | No. 1,910of 33,687 Better than 94% |
| All companies of type ApS66,508 companies in the comparison | No. 2,765of 66,379 Better than 96% | No. 3,490of 66,505 Better than 95% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing supplies- Hipra Nordic ApSDKK 18.3m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Hipra Nordic ApSDKK 4.5m
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
- Hipra Nordic ApSDKK 26.2m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
- Hipra Nordic ApS8
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Laboratorios Hipra, S.A.100%
Management
2 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Maria Del Mar Nogareda Estivill | Director | 25/07/2013 |
| David Caballero Tomás | Director | 21/02/2025 |
- Founders
- Laboratorios HIPRA, S.A
Former management (3)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| David Nogareda Estivill | Director | 25/07/2013 | 20/02/2025 |
| Carlos Montañes Estupiña | Director | 25/07/2013 | 20/02/2025 |
| Peter Cyriel A.Saey | Director | 21/02/2025 | 30/09/2026 |
Signing rule: Selskabet tegnes af en direktør.
Address and production units
1 active production unitsÅdalen 7C
6600 Vejen
Vejen Municipality · Postcode 6600
Other companies at the address (1)
- Falco A/SWholesale of other machinery and equipment
| Production unit | Address | Employees | P number |
|---|---|---|---|
| HIPRA NORDIC ApS | Ådalen 7C, 6600 Vejen | 8 | 1018661450 |
Purpose
Selskabets formål er udvikling, import og eksport, handel både engros og detail, produktion af, levering af og distribution af alle slags biologiske, farmaceutiske, kemiske, medicinske, diagnosticerende udstyr, veterinærpro-dukter og dermed beslægtede produkter. Selskabet skal fortsætte forskning og udviklingsarbejde, markedsføring, salgsfremmende, teknisk og veterinær rådgivningsservice i forbindelse med alle slags dyrehelbredsprodukter og rådgivning, hvis det af direktørerne skønnes fordelagtigt for selskabet og dermed beslægtet virksomhed efter bestyrelsens skøn.
The purpose is quoted from the register in Danish.
Changes year by year
22 registered events20262 changesmanagement 1 · accounts 1
- ManagementPeter Cyriel A.Saey stepped down as director
- AccountsAnnual report for 2025 published
20255 changesaccounts 1 · management 4
- AccountsAnnual report for 2024 published
- ManagementPeter Cyriel A.Saey appointed director
- ManagementDavid Caballero Tomás appointed director
- ManagementDavid Nogareda Estivill stepped down as director
- ManagementCarlos Montañes Estupiña stepped down as director
20241 changeaccounts 1
- AccountsAnnual report for 2023 published
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20222 changesaddress 1 · accounts 1
- AddressMoved to Ådalen 7C, 6600 Vejen
- AccountsAnnual report for 2021 published
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20171 changeaddress 1
- AddressMoved to Ådalen 7C, 6600 Vejen
20161 changename 1
- NameName changed from HIPRA DANMARK ApS to HIPRA NORDIC ApS
20143 changescapital 1 · address 1 · industry 1
- CapitalShare capital changed from 320,000 DKK to 4,320,000 DKK
- AddressMoved to Haderslevvej 36, 6000 Kolding
- IndustryIndustry changed to Wholesale of pharmaceutical goods and nursing supplies (464610)
20135 changesownership 1 · founded 1 · management 3
- OwnershipLaboratorios Hipra, S.A. registered as owner (100%)
- FoundedRegistered as HIPRA DANMARK ApS
- ManagementDavid Nogareda Estivill appointed director
- ManagementCarlos Montañes Estupiña appointed director
- ManagementMaria Del Mar Nogareda Estivill appointed director
Related companies
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.